Latest China Shenghuo Pharmaceutical (CKUN) Headli
Post# of 2
The Special Committee of China Shenghuo Pharmaceutical Accepts Going Private Proposal From Lan's Int'l Medicine Investment Co., Limited at $0.16 per Share to Be Effected Through a Reverse Stock Split
Marketwire - Tue Apr 16, 7:00AM CDT
China Shenghuo Pharmaceutical Holdings, Inc. (PINKSHEETS: CKUN) ("China Shenghuo" or the "Company"), today announced that the special committee consisting solely of independent directors (the "Special Committee") has accepted an offer from Lan's Int'l Medicine Investment Co., Limited ("LIMI") to take the Company private (the "Going Private Transaction") by effecting a reverse stock split followed by a cancellation of all fractional shares below one whole share at a per share price of $0.16 (the "Going Private Proposal"). LIMI has agreed to fund the payout of fractional shares.
China Shenghuo Pharmaceutical Reports Unaudited Financial Results for the Full Year 2012
Marketwire - Mon Mar 25, 7:01AM CDT
China Shenghuo Pharmaceutical Holdings, Inc. (PINKSHEETS: CKUN) ("China Shenghuo" or the "Company") today announced unaudited financial results for the year ended December 31, 2012. Such unaudited financial results were prepared by management in compliance with United States Generally Accepted Accounting Practices, except for the absence of notes to the financial statements.
China Shenghuo Pharmaceutical Announces Receipt of Non-Binding Going Private Proposal From Lan's Int'l Medicine Investment Co., Limited at $0.15 per Share
Marketwire - Fri Feb 15, 7:00AM CST
China Shenghuo Pharmaceutical Holdings, Inc. (PINKSHEETS: CKUN) ("China Shenghuo" or the "Company") today announced that its Board of Directors (the "Board") received a preliminary, non-binding proposal from Lan's Int'l Medicine Investment Co., Limited ("LIMI"), in which LIMI proposed that the Board consider a "going private" transaction to cash out the public shareholders of the Company at a price of $0.15 per share, to be funded by LIMI if necessary (the "LIMI Proposal"). LIMI currently owns approximately 77.3% of the Company's outstanding common stock.